Smartphone app found to be valid tool in screening for minimal hepatic encephalopathy

September 18, 2013, Virginia Commonwealth University

A smartphone app can quickly screen for cognitive dysfunction often found in patients with cirrhosis, according to a new Virginia Commonwealth University study. The cognitive dysfunction, known as minimal hepatic encephalopathy (MHE), has been difficult to diagnose.

Published in the September issue of the journal Hepatology, the study tested the validity of the Stroop smartphone application – called EncephalApp_Stroop – as a method to screen for MHE.

Validation of the as a health care tool opens the door for its use as a point-of-care (POC) instrument that providers can use to quickly, easily and confidently evaluate their patients who may be suffering from MHE.

"This app can be used to rapidly select which patients are likely to benefit from further MHE testing and potential treatment, which has been lacking at this time." said principal investigator Jasmohan Bajaj, M.D., associate professor, Department of Gastroenterology, Hepatology and Nutrition, VCU School of Medicine, who practices at VCU and McGuire VA Medical Centers. "It can be translated into practice by clinic assistants, nurses or other non-MD professionals to add a cost-effective approach to the rapid diagnosis of MHE."

MHE is associated with impaired quality of life, employment and driving capability and a higher risk of progression to overt hepatic encephalopathy, but treatment has not been standard of care in the U.S. partly because MHE testing is not feasible.

The free EncephalApp_Stroop app, which Bajaj developed, utilizes the Stroop task, which is used to evaluate psychomotor speed and through identification in various combinations of ink colors and words.

To determine the validity of the app as a health care tool, Bajaj and his team recruited 126 patients with , some of whom had overt , 51 age-balanced health controls and 43 additional patients with cirrhosis for the prospective validation cohort. They underwent a battery of recommended cognitive tests including the traditional MHE test and the Stroop app evaluation.

The team concluded that the Stroop app is a valid, reliable method for screening for MHE. Use of the app may improve the screening process by making it easier and faster and, subsequently, increase treatment rates in potential with MHE.

They suggest further studies evaluating the app's validity in other populations are needed.

The app can be downloaded on iTunes for iPhones or iPads and is available in Spanish, Czech, Slovak and Indonesian languages.

Explore further: Detection and treatment for hepatic encephalopathy prevents car accidents, reduces costs

Related Stories

Detection and treatment for hepatic encephalopathy prevents car accidents, reduces costs

March 27, 2012
A late stage liver condition, known as minimal hepatic encephalopathy (MHE), is associated with impaired driving skills and greater risk of motor vehicle accidents. Cost analysis of management strategies for detection and ...

New app from UK researcher helps clinician communications

September 17, 2013
There's an app for that. A new iOS app developed in part by University of Kentucky researcher Elaine Wittenberg-Lyles will assist health care professionals seeking help communicating with patients during difficult conversations.

Phone app helps doctors make right call in treating heart patients

September 3, 2013
A smart phone app could help doctors more easily identify patients who are at risk of dying within three years a heart attack.

Technology takes on breast cancer

July 17, 2013
(Medical Xpress)—An ANU student has developed a smartphone app for the early detection of breast cancer.

Recommended for you

Nanoparticle vaccine offers universal protection against influenza A viruses, study finds

January 24, 2018
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia ...

Leprosy's drug resistance and origin revealed by genome analysis

January 24, 2018
Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes. Despite being curable with multidrug therapy, leprosy still persists in many developing ...

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.